← Eichor
Study identifier: NCT07437404 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Efficacy and Safety Evaluation Study of SCT800 in Previously Untreated Hemophilia A Patients.

Condition: Haemophilia A  ·  Sponsor: Sinocelltech Ltd.

PhasePhase 3
Planned participants36
Who can joinMale, N/A to 6 Years
Healthy volunteersNo

About this study

This is an Open Label, Uncontrolled Study to Evaluate the the Safety and Efficacy of SCT800 for Prophylaxis Treatment in Severe Previously Untreated Hemophilia Patients.

This description comes directly from the study's public registry record.

Talk to the study team

Runhui Wu  ·  +86-13370115037  ·  wurunhuigcp@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

Beijing children's hospitalBeijing, Beijing Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07437404